Trump order on regulations could create hurdles for FDA, Cures Act

Trump order on regulations could create hurdles for FDA, Cures Act-stat: President Trump on Monday signed an executive order directing federal agencies to cut two regulations for every new one that they adopt, a move that could have significant implications for the Food and Drug Administration.

Opinion: The FDA’s Accelerated Approval Process is Working

Opinion: The FDA’s Accelerated Approval Process is Working-morningconsult: It goes without saying that the passage of the 21st Century Cures Act by an overwhelming bipartisan majority vote will help speed up the delivery of innovative treatments to patients. There’s now an opportunity to take a step back and assess how we can build on this bipartisan achievement.

Cures Act Gains Bipartisan Support That Eluded Obama Health Law

Cures Act Gains Bipartisan Support That Eluded Obama Health Law-nytimes: With self-congratulatory zeal and smiles all around, huge bipartisan majorities in Congress have just passed legislation to speed the discovery of cures for killer diseases. At the same time, Republican leaders have been devising a strategy to undo the Affordable Care Act, which has done more than any law in a generation to treat people with those diseases.

McConnell tees up medical cures bill

McConnell tees up medical cures bill-thehill: Senate Majority Leader Mitch McConnell (R-Ky.) is turning attention toward a medical innovation bill that is receiving pushback from liberals.

House OKs bill bolstering medical research, drug approvals

House OKs bill bolstering medical research, drug approvals-ap: The House easily approved a sweeping biomedical bill Wednesday that would help drug and medical device companies win swifter government approval of their products, boost disease research and drug-abuse spending and revamp federal mental health programs.

$6.3 Billion Measure Aims to Cure Ailing Health Care Policies

$6.3 Billion Measure Aims to Cure Ailing Health Care Policies-nytimes: In one of the most sweeping and rare bipartisan acts of this Congress, lawmakers will move this week on a $6.3 billion bill to increase funding for research into cancer and other diseases, address problems in the nation’s mental health systems and enact potentially far-reaching regulatory changes for drugs and medical devices.

Grassley Threatens to Hold Up Cures if Disclosure Requirements Are Weakened

Grassley Threatens to Hold Up Cures if Disclosure Requirements Are Weakened-morningconsult: Sen. Chuck Grassley (R-Iowa) says he will object to the Senate passing a major health care bill by unanimous consent because it would weaken disclosure requirements between industry players and health care providers.

Republicans reach deal to pass Cures Act by end of year, but Democrats pushing for changes

Republicans reach deal to pass Cures Act by end of year, but Democrats pushing for changes-stat: House and Senate leaders announced late Friday night that they had finally hammered out a deal on landmark legislation designed to speed federal approval of new drugs and devices and boost funding of medical research.

Conservative Groups Warn Against Including Bill Targeting Generics in Cures Act

Conservative Groups Warn Against Including Bill Targeting Generics in Cures Act-morningconsult: Ten conservative organizations are warning lawmakers against adding a measure they say could cause unnecessary health risks to a medical innovation bill top lawmakers hope to advance before the year ends.

Pelosi Says Democrats Aren’t in Agreement on Cures Act

Pelosi Says Democrats Aren’t in Agreement on Cures Act-morningconsult: House Minority Leader Nancy Pelosi says House Democrats don’t unanimously back the 21st Century Cures package, which advocates hope will come up for a vote in both chambers of Congress during the upcoming lame-duck session.

Medical cures bill pushed back to lame-duck

Medical cures bill pushed back to lame-duck-thehill: Legislation to speed the approval of new medical cures will not move in Congress before lawmakers leave town for the election despite a last-minute push, lobbyists and aides said.

Cures Bill Proponents Aim for September Vote

Cures Bill Proponents Aim for September Vote-morningconsult: As lawmakers prepare to head back to Capitol Hill next week, the heads of influential committees on health will make a strong push to pass major medical innovation legislation in September.

Senate delays Cures bill, as window for major legislation narrows

Senate delays Cures bill, as window for major legislation narrows-stat: Lawmakers are officially giving up hopes of considering a bill to speed the development of new medical cures before they leave town for an extended recess, sharply increasingly the likelihood that the legislation might have to be taken up by the next Congress.

Senate Panel Punts on Big Medical Bill

Senate Panel Punts on Big Medical Bill-morningconsult: The Senate will not put forth a comprehensive medical innovation bill that would be a companion measure to the House’s 21st Century Cures bill. Instead, lawmakers are opting to work on several smaller bills that have bipartisan support. In recent weeks, aides said committee members hit partisan snags when discussing a bigger bill.

Senate chairman: Cures bill is next priority

Senate chairman: Cures bill is next priority-thehill: The Senate Health Committee will be turning its attention to a medical innovation bill now that it has completed the overhaul of No Child Left Behind, Chairman Lamar Alexander (R-Tenn.) said. “No. 1, what we want to turn our attention to next is what we call our innovation bill,” Alexander said on C-SPAN’s “Newsmakers.”

More money pledged for NIH but questions remain

More money pledged for NIH but questions remain-thehill: Hopes are rising for an increase in funding for the National Institutes of Health after a budget deal, even as negotiators haggle over a longer-term increase in a separate bill.  The push for increased funding for medical research at NIH is a rare area of bipartisan consensus, but the budget caps put in place in 2011 had posed an obstacle. The agreement sealed late last month, which lifted the cap for domestic spending by $40 billion over the next two years, is providing a new ray of hope.

Budget deal sets back key healthcare bills

Budget deal sets back key healthcare bills-thehill: Congress’s two-year budget deal is throwing up hurdles for a pair of healthcare bills, taking away almost $13 billion in offsets that had been proposed to pay for the legislation.  Both bills have already passed the House and are expected to reach the Senate sometime before 2016. One of those — the 21st Century Cures Act — passed with nearly 350 votes as lawmakers rallied behind the push for streamlined drug approvals and a boost in medical research funding.

Lawmakers enlist researchers and patient advocates to support 21st Century Cures bill

Lawmakers enlist researchers and patient advocates to support 21st Century Cures bill-modernhealthcare: Congressman Bob Dold of Illinois on Monday tapped researchers and patient advocates in Chicago to help support the 21st Century Cures Act. Nearly $9 billion in funding for the National Institutes of Health is meant to advance medical innovations.

Senate Lukewarm On Mandatory NIH Funding As Researchers Seek Funds

Senate Lukewarm On Mandatory NIH Funding As Researchers Seek Funds-insidehealthpolicy: As the Senate health committee continues work on its Innovation for Healthier Americans initiative, sources say the upper chamber has not shown much interest in pursuing a mandatory funding stream for the National Institute of Health as was included in the recently passed House 21st Century Cures bill.

The Senate’s ‘Cures’ Bill Is Coming…Next Year

The Senate’s ‘Cures’ Bill Is Coming…Next Year-morningconsult: Sen. Lamar Alexander (R-Tenn.) said Monday that the Senate would not take up House-passed legislation this year that aims to expedite the approval of new medical cures, adding that he expects the chamber will pass its own version in 2016, despite it being an election year.